Global Artificial Insemination Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028
“Global Artificial Insemination Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global artificial insemination market report has been segmented on the basis of type, end use, source type, and region.
Global Artificial Insemination Market: Overview
Intrauterine insemination is a fertility treatment that involves placing sperm inside a woman’s uterus to facilitate fertilization. The goal of IUI is to increase number of sperm that reach fallopian tubes and subsequently increase the chance of fertilization. IUI provides sperm an advantage by giving it a head start, but still requires a sperm to reach and fertilize the egg on its own. It is a less invasive and less expensive option compared to in vitro fertilization.
Before intrauterine insemination ovulation-stimulating medications may be used in which careful monitoring will be necessary to determine when eggs are mature. The IUI procedure will then be performed around the time of ovulation, typically about 24-36 hours after the surge in LH hormone that indicates ovulation will occur soon.
Global Artificial Insemination Market: Dynamics
Increasing spending capacity, changing lifestyle pattern is resulting in increasing pregnancy related problems which is a major factor expected to drive growth of the global market. In addition, rising awareness and social acceptance related to artificial insemination in developed and developing countries is another factor expected to further support growth of the global market.
Moreover, developing regulatory scenario related to artificial insemination is expected to further boost growth of the global market.
However, high risk of conceiving twins or triplets and other complications such as premature birth or miscarriage are some major factors expected to limit adoption of artificial insemination, which is expected to hamper growth of the global market. In addition, non-favorable regulatory scenario and lack of social acceptance in developing countries are some major factors expected to hamper growth of the global market.
Increasing investment by major players for technological advancements is expected to create potential revenue opportunities in terms of revenue for players operating in the target market over the forecast period. In addition, increasing public private partnership for R&D activities is expected to further support growth of the global market to certain extent.
Global Artificial Insemination Market: Segment
Among the product type segments, the intrauterine insemination segment is expected to dominate in the target market over the forecast period.
Among the end use segments, the fertility clinics segment is expected to contribute significant revenue shares in the target market over the forecast period.
Global Artificial Insemination Market: Region
The market in North America is expected to dominate in the global market and is expected to continue its dominance over the forecast period. This can be attributed to well-developed infrastructural, high percentage of infertility issues among women, and presence of major players operating in the countries in this region. In addition, increasing merger and acquisition activities between regional and international players for technological advancements is expected to further support growth of the market in this region.
The market in Asia Pacific is expected to witness fastest growth, owing to increasing government expenditure in development of healthcare infrastructure, rising awareness related to artificial insemination, and presence of prominent players operating in the emerging economies in this region.
Global Artificial Insemination Market Segmentation
Segmentation by type
- Intrauterine Insemination
- Intracervical Insemination
- Intravaginal Insemination
- Intratubal Insemination
Segmentation by end-use
- Fertility Clinics
Segmentation by source type
- AIH - Husband
- AID – Donor
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2028 Revenue in US$
- Vitrolife AB
- Genea Limited
- Rinovum Women’s Health LLC
- Pride Angel
- Hi-Tech Solutions, Inc.
- Irvine Scientific Sales Company, Inc.
- Kitazato Biopharma Co., Ltd.
- Rocket Medical PLC
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!